Showing results (81-90 of 1,283) with videos related to

Sort By:
Pageof 129
Cancer Research|June 1, 1976
The effect of adriamycin on the cell cycle traverse of a human lymphoid cell lineB Barlogie, B Drewinko, D A Johnston, et al.
Annals of Internal Medicine|December 15, 1991
High serum lactate dehydrogenase level as a marker for drug resistance and short survival in multiple myelomaM A Dimopoulos, B Barlogie, T L Smith, et al.
Cancer Research|June 1, 1983
Comparative cytotoxicity of bisantrene, mitoxantrone, ametantrone, dihydroxyanthracenedione, dihydroxyanthracenedione diacetate, and doxorubicin on human cells in vitroB Drewinko, L Y Yang, B Barlogie, et al.
Cancer Research|April 1, 1981
Reduction of 1-beta-D-arabinofuranosylcytosine and adriamycin cytotoxicity following cell cycle arrest by anguidineL Teodori, B Barlogie, B Drewinko, et al.
Cancer Research|September 1, 1981
Biological properties of the human colonic adenocarcinoma cell line SW 620 grown as a xenograft in the athymic mouseJ J Stragand, B Barlogie, R A White, et al.
Cell and Tissue Kinetics|September 1, 1984
Cultured human tumour cells may be arrested in all stages of the cycle during stationary phase: demonstration of quiescent cells in G1, S and G2 phaseB Drewinko, L Y Yang, B Barlogie, et al.
Seminars in Oncology|October 21, 1999
Novel approaches in myeloma therapyN C Munshi, B Barlogie, K R Desikan, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1984
High-dose cytosine arabinoside in multiple myelomaH Kantarjian, R Dreicer, B Barlogie, et al.
Critical Reviews in Oncology/Hematology|March 14, 2003
Angiogenesis in hematologic malignanciesT M Moehler, A D Ho, H Goldschmidt, et al.
Cancer Research|July 1, 1976
Kinetic response of human lymphoid cells to adriamycin-DNA complex in vitroB Barlogie, B Drewinko, R S Benjamin, et al.
Pageof 129